I've always been behind MANF. The company is finally getting MANF off the ground. If it had been organized, and credible, this would have happened several years ago. Even with that, they add in a preposterous statement that MANF will be used for Glaucoma. ah, no, not in any size, and probably not at all, since there are lots of treatments for Glaucoma.
The mendacity of this company is deep rooted. It will continue to bedevil the company until those who just must confabulate are removed. Your comment reminds me of the FIRST day in Copenhagen. The company released a "Positive" study that had nothing to do with being positive or negative and the pps skyrocketed. Discerning stock holders make so much money off this company because they know when the company is lying.
MANF has potential, ESS when they close on it, is a real product, and P16 bears investigating.
The others are crap more than likely, although Eltoprazine bears investigating. Lympro is a ruse to keep up the share price. It actually did work, now the pps will trade on the MANF/ESS news for some time.
News 
Market Data 
Discover 
